Analysis of the potential of the medical cannabis market in the European continent

During only 2018, the European market for the production and consumption of therapeutic properties of hemp has grown several times. About 500 million euros have already been invested in the EU cannabis market, which until recently was presented as separate foreign-made pharmacological preparations. According to experts at the HempConsulting information and analytical platform, Europe will become the world's largest legitimate market for therapeutic hemp in the next five years. Over 740 million people live here (the solvent population more than doubles the number of citizens of the United States and Canada in total). According to experts, the therapeutic hemp market in Europe will reach € 123 billion by 2028.

The study presents an analysis of the medical cannabis market emerging on the European continent, the information on which is structured as follows

                                                                                                                                                                                                                                                                                                                      EU policy on the use of therapeutic properties of hemp

Introduction 1

Europe

  Austria 11

  Belgium 12

 Great Britain 13

 Germany 16

 Greece 17

 Denmark 19

 Ireland 21

 Spain 22

 Italy 23

 Latvia 25

 Lithuania 26

 Luxembourg 27

 Malta 28

 Netherlands 29

 Norway 32

 Poland 33

 Portugal 35

 Romania 36

 North Macedonia 38

 Serbia 39

 Slovakia 40

 Slovenia 41

 Turkey 42

 Ukraine 43

 Finland 45

 France 47

 Croatia 50

 Czech 51

 Switzerland 53

 Sweden 55

 Estonia 57

Asia / Near East

 Georgia 58

 Israel 60

 Lebanon 62

Tables 63